Tan, S.; Kaya, B.; Akburak, E.; Avci, C.; Ates, K.E.; Gonlusen, G.; Ercakalli, T.S.; Mete, B.
The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats. Biomedicines 2025, 13, 1582.
https://doi.org/10.3390/biomedicines13071582
AMA Style
Tan S, Kaya B, Akburak E, Avci C, Ates KE, Gonlusen G, Ercakalli TS, Mete B.
The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats. Biomedicines. 2025; 13(7):1582.
https://doi.org/10.3390/biomedicines13071582
Chicago/Turabian Style
Tan, Seyhmus, Bulent Kaya, Ercan Akburak, Cagri Avci, Kivilcim Eren Ates, Gulfiliz Gonlusen, Tugce Sapmaz Ercakalli, and Burak Mete.
2025. "The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats" Biomedicines 13, no. 7: 1582.
https://doi.org/10.3390/biomedicines13071582
APA Style
Tan, S., Kaya, B., Akburak, E., Avci, C., Ates, K. E., Gonlusen, G., Ercakalli, T. S., & Mete, B.
(2025). The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats. Biomedicines, 13(7), 1582.
https://doi.org/10.3390/biomedicines13071582